Nimotuzumab Biosimilar - Research Grade [ICH4008]
Bulk Nimotuzumab Biosimilar - Research Grade
Product Specific Citations:
Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022).
ichorbio's Nimotuzumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.
ichorbio's research grade nimotuzumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our nimotuzumab biosimilar - please contact us for pricing.
Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
Detects human EGFR.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Nimotuzumab biosimilar has a humanized human-mouse h-R3 heavy chain and a humanized human-mouse h-R3κ-chain. nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division.
1.0 - 5.0 mg/ml
Sterile, clear, colorless solution without preservatives, containing sodium dihydrogen phosphate, phosphoric acid disodium hydrogen, sodium chloride and polysorbate 80. BSA and Azide free.
>95% by SDS-PAGE and HPLC
≤ 0.75 EU/mg as determined by the LAL method
This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's nimotuzumab biosimilar is for research use only (RUO). Isotype Control: